Attached files

file filename
10-K - ANNUAL REPORT - Organicell Regenerative Medicine, Inc.organicell_10k-103117.htm
EX-32.1 - CERTIFICATION - Organicell Regenerative Medicine, Inc.organicell_ex3201.htm
EX-31.2 - CERTIFICATION - Organicell Regenerative Medicine, Inc.organicell_ex3102.htm
EX-31.1 - CERTIFICATION - Organicell Regenerative Medicine, Inc.organicell_ex3101.htm
EX-10.32 - FORM OF 2018 6% CONVERTIBLE DEBENTURE - Organicell Regenerative Medicine, Inc.organicell_ex1033.htm
EX-3.9 - CERTIFICATE OF WITHDRAWAL - Organicell Regenerative Medicine, Inc.organicell_ex0309.htm
EX-3.8 - CERTIFICATE OF COIRRECTION - Organicell Regenerative Medicine, Inc.organicell_ex0308.htm
EX-3.7 - CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION - Organicell Regenerative Medicine, Inc.organicell_ex0307.htm

Exhibit 21.1

 

SUBSIDIARIES OF THE REGISTRANT

        

Below is a list of subsidiaries of Organicell Regenerative Medicine, Inc. (the “Company”), all of which are wholly-owned by the Company, other than noted by an asterisk*.

        

Subsidiary Name:

Date of

Formation:

State of Formation:
1.       ANU Life Sciences, Inc. 8/4/16 FL
2.       BD Source and Distribution Corp. 7/23/15 FL
3.       Beyond Cells Corp. 7/22/15 FL
4.       Ethan New York, Inc. 8/10/15 NY

5.       General Surgical Florida, Inc.

1/15/16 FL
6.       Mint Organics, Inc.* 2/28/17 FL
7.       Mint Organics Florida, Inc.* 2/28/17 FL

 

* Mint Organics and Mint Organics Florida have issued minority non-voting equity interests.